Provectus presenting at today’s “BIO CEO & Investor Conference”
Knoxville-based Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology company, is scheduled to make a presentation at 3 p.m. today at the “18th Annual BIO CEO & Investor Conference” in New York City.
The presentation will be webcast live. Those interested in watching it can do so via this link.
The New York City event is billed as one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. It provides a forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.